Betamethasone- and salicylic acid-containing product in cutaneous dose form 772347008
SNOMED CT code
SNOMED code | 772347008 |
---|---|
name | Betamethasone- and salicylic acid-containing product in cutaneous dose form |
status | active |
date introduced | 2019-01-31 |
fully specified name(s) | Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form) |
synonyms | Betamethasone- and salicylic acid-containing product in cutaneous dose form |
attributes - group0 | |
Has manufactured dose form | Cutaneous dose form 740596000 |
Plays role | Antifungal therapeutic role 788020005 |
attributes - group1 | |
Has active ingredient | Betamethasone 116571008 |
attributes - group2 | |
Has active ingredient | Salicylic acid 387253001 |
parents | |
children | Betamethasone and salicylic acid only product in cutaneous dose form 778501009 |
hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by disposition 766779001 Immunomodulator-containing product 108940007 Betamethasone-containing product 29896003 Betamethasone- and salicylic acid-containing product 346347008 Betamethasone- and salicylic acid-containing product in cutaneous dose form 772347008 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as cutaneous dose form 767314005 Betamethasone-containing product in cutaneous dose form 771741009 Betamethasone- and salicylic acid-containing product in cutaneous dose form 772347008 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as cutaneous dose form 767314005 Salicylic acid-containing product in cutaneous dose form 771900008 Betamethasone- and salicylic acid-containing product in cutaneous dose form 772347008 |
ancestors | sorted most to least specific
|
cpt crosswalks |
Thank you for choosing Find-A-Code, please Sign In to remove ads.